MacroGenics Inc Earnings

The next earnings date for MacroGenics Inc is February 19, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of MacroGenics Inc Earnings

Report DateEstimated Earnings Per Share
02/19/2026$-0.27

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

MacroGenics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/11/2025---$0100.00%
08/12/2025---$0100.00%
05/07/2025Before Market$-0.655.80%
03/05/2025Before Market------
11/05/2024After Market$0.90328.57%
08/06/2024After Market$-0.89-50.85%
05/09/2024After Market$-0.84-31.25%
03/07/2024After Market$-0.75-400.00%
11/06/2023After Market$0.28380.00%
08/09/2023After Market$-0.69-32.69%
05/09/2023After Market$-0.61-235.56%
03/15/2023After Market$0.21110.00%
11/03/2022After Market$-0.40-5.26%
08/08/2022After Market$-0.6730.93%
05/03/2022After Market$-1.08-25.58%
02/24/2022After Market$-0.95-17.28%
11/02/2021After Market$-0.86-24.64%
07/29/2021After Market$-0.66-43.48%
04/29/2021After Market$-0.90-47.54%
02/25/2021After Market$-0.0493.33%
11/04/2020After Market$-0.6629.03%
07/30/2020After Market$-0.94-2.17%
05/05/2020After Market$-0.9110.78%
02/25/2020After Market$-0.6139.60%
11/06/2019After Market$-0.917.14%
07/31/2019After Market$-1.05-6.06%
05/01/2019After Market$-0.99-15.12%
02/26/2019After Market$-1.06-3.92%
11/07/2018After Market$-0.8138.64%
08/07/2018After Market$-1.0315.57%
05/07/2018After Market$-1.34-24.07%
02/27/2018After Market$2.9633.94%
11/08/2017After Market$-1.28-18.52%
08/02/2017After Market$-1.14-37.35%
05/03/2017After Market$-1.08-11.34%
02/28/2017After Market$-1-12.36%
11/02/2016After Market$-0.97-21.25%
08/03/2016After Market$1.125,700.00%
05/04/2016After Market$-0.88-31.34%
02/29/2016After Market$-0.88-51.72%
11/04/2015After Market$-0.46-76.92%
08/05/2015After Market$-0.71-61.36%
05/06/2015After Market$1.42-2.74%
03/03/2015After Market$-0.69-97.14%
11/11/2014After Market$-0.1466.67%
08/05/2014---$-0.44-51.72%
05/06/2014---$-0.12-50.00%
03/20/2014---$-0.1448.15%
11/12/2013---$0.01-94.74%

More About MacroGenics Inc

Country
USA
Full Time Employees
341

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.

MacroGenics Inc Earnings” Can Refer to the MacroGenics Inc Earnings Date

Some people say “MacroGenics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my MacroGenics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning MacroGenics Inc Stock on the Earnings Date

If you own MacroGenics Inc stock (MGNX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for MacroGenics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading MacroGenics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More MacroGenics Inc Earnings

You can contact us any time if you would like to ask questions about MacroGenics Inc earnings or anything else related to the stock market.